Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity

v3.20.1
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning Balance at Dec. 31, 2018 $ 2,728 $ 4 $ 173,962 $ (92) $ (171,146)
Balance (in shares) at Dec. 31, 2018   4,198      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (6,551)       (6,551)
Equity financing, net (in shares)   291      
Equity financing, net 7,305   7,305    
Equipois sales earn-out 22   22    
Equipois sales earn-outs (in shares)   1      
Equity incentive plan 55   55    
Equity incentive plan (in shares)   3      
Matching contribution to 401(k) plan 191   191    
Matching contribution to 401(k) plan (in shares)   9      
Stock-based compensation expense 636   636    
Foreign currency translation adjustments 148     148  
Ending Balance at Mar. 31, 2019 4,534 $ 4 182,171 56 (177,697)
Balance (in shares) at Mar. 31, 2019   4,502      
Beginning Balance at Dec. 31, 2019 6,797 $ 6 190,019 50 (183,278)
Balance (in shares) at Dec. 31, 2019   5,795      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (2,534)       (2,534)
Matching contribution to 401(k) plan 155   155    
Matching contribution to 401(k) plan (in shares)   26      
In lieu of cash compensation 50   50    
In lieu of cash compensation (in shares)   9      
Shares issued as a result of rounding due to reverse-stock split (in shares)   13      
Stock-based compensation expense 587   587    
Foreign currency translation adjustments 173     173  
Ending Balance at Mar. 31, 2020 $ 5,228 $ 6 $ 190,811 $ 223 $ (185,812)
Balance (in shares) at Mar. 31, 2020   5,843